Locatim, Oral Solution for Neonatal Calves Less Than 12 Hours of Age

Country: United Kingdom

Language: English

Source: VMD (Veterinary Medicines Directorate)

Active ingredient:

Bovine concentrated lactoserum

Available from:

Biokema Anstalt

ATC code:

QI02AT01

INN (International Name):

Bovine concentrated lactoserum

Pharmaceutical form:

Oral solution

Prescription type:

POM-VPS -Prescription Only Medicine – Veterinarian, Pharmacist, Suitably Qualified Person

Therapeutic group:

Cattle

Therapeutic area:

Lactoserum

Authorization status:

Authorized

Authorization date:

1999-03-29

Summary of Product characteristics

Revised: January 2022
AN: 00148/2021
Page 1 of 4
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Locatim, oral solution for neonatal calves less than 12 hours of age
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
ACTIVE SUBSTANCE
Bovine concentrated lactoserum containing specific immunoglobulins G
against _E. _
_coli_ F5 (K99) adhesin

2.8* log
10
/ml.
* ELISA method
EXCIPIENT
Methyl parahydroxybenzoate

0.8 mg/ml.
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Oral solution
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Neonatal calves less than 12 hours of age.
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Reduction of mortality caused by enterotoxicosis associated with _E.
coli_ F5 (K99)
adhesin during the first days of life as a supplement to colostrum
from the dam.
4.3
CONTRAINDICATIONS
None.
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
The product is produced from colostrum collected from cows kept under
field
conditions. Consequently, in addition to antibodies to _E. coli_ F5
(K99) it also contains
antibodies to other organisms, as a result of vaccination and/or
exposure of the
donor cows to organisms in their environment.
This should be borne in mind when planning vaccination programmes for
calves,
which receive Locatim.
Revised: January 2022
AN: 00148/2021
Page 2 of 4
4.5
SPECIAL PRECAUTIONS FOR USE
Special precautions for use in animals
This product may contain antibodies against BVD virus.
Special precautions to be taken by the person administering the
veterinary medicinal
product to animals
Not applicable.
4.6
ADVERSE REACTIONS (FREQUENCY AND SERIOUSNESS)
None known.
4.7
USE DURING PREGNANCY OR LACTATION
The product is not intended for use during pregnancy and lactation.
4.8
INTERACTION WITH OTHER MEDICINAL PRODUCTS AND OTHER FORMS OF
INTERACTION
No information is available on the safety and efficacy of this
immunological veterinary
medicinal product when used with any other veterinary medicinal
product. A decision
to use this immunologi